Canada invests millions more in domestic drug development to combat COVID-19

The federal government is investing millions of new dollars to boost Canada’s domestic vaccine and drug development capacity.

Innovation Minister Francois-Philippe Champagne says Canada must build and expand homegrown biomanufacturing facilities and develop more equipment to secure more vaccines and therapeutics to combat COVID-19.

Ottawa will contribute up to $54.2 million to KABS Laboratories and up to $13.44 million to Immune Biosolutions to expand their respective operations in Quebec.

Get breaking National news

For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen.

Sign up for breaking National newsletter Sign Up

By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

It will also provide up to $32.7 million to Novocol Pharmeceutical of Canada for growth of its biomanufacturing facilities in Ontario.

0:49 Trudeau announces $518 million to support innovation and research in Canada

Ottawa is also investing $150 million to help companies advance through the early stages of research and development of several Canadian-made vaccine candidates.